The findings of this work demonstrated that myco-fabricated ZnO-NPs provide neuro-amelioration against an experimental AD model caused by AlCl3 through reducing IL1 β, TNF-ἀ, MDA, and activity of AChE and increasing production of GSH, SOD, and CAT. Here, CAT is linked to Alzheimer disease.